Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)

Name: Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)
Published: 2016
License: Public Domain

Daiichi Sankyo · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

acute-myeloid-leukemia chemotherapy leukemia

acute myeloid leukemia, leukemia, newly diagnosed acute myeloid leukemia, flt3-itd positive, chemotherapy, induction chemotherapy, consolidation chemotherapy, quizartinib, feline mcdonough sarcoma (fms)-like tyrosine kinase 3, ac220, flt3-itd, aml

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1032448
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.